NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BenchSci

BenchSci

Private
TorontoHealthcare & Life Scienceshttps://www.benchsci.com/

Last Round

Series D

May 25, 2023

Total Funding Raised

$159.94M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

BenchSci is a biotechnology company that offers a research intelligence platform leveraging machine learning and artificial intelligence to optimize antibody extraction experiments, helping researchers accelerate biomedical discoveries efficiently.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

drug discoveryAI drug discoverypreclinical researchbiomedical databiological evidence knowledge graphBEKGAI copilotscientific research platformR&D softwareexperimental designpharma techbiotech softwarelab-in-the-loopdrug target identificationenterprise SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BenchSci Comparables

Compare BenchSci with similar companies based on industry and business-model similarity.

BenchSci comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insilico Medicine
87%
Causaly
85%
Biorelate
78%

BenchSci Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMay 25, 2023
Series CJan 24, 2022
Series BFeb 4, 2020
Series A ExtensionJun 25, 2019
Series AMay 2, 2018
Seed
Jul 1, 2017

Key People

Founding team and executive leadership

Liran Belenzon

Co-founder And CEO

Founding Team

BenchSci Investors

Notable investors and investment history

BenchSci investors
InvestorRounds
Gradient VenturesSeries B, Series A, Series D, Series C, Series A Extension
Northleaf Capital PartnersSeries B, Series C
Fidelity Investments Canada ULCSeries D, Series C, Series B
TCVSeries D, Series C
Inovia CapitalSeries B, Series D, Series A Extension, Series A, Series C
F-Prime CapitalSeries D, Series C, Series B
Creative Destruction LabPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Achieved 247% growth over three years, recognized by Deloitte.

  • Apr 21, 2026

    Platform used by 9 of top 10 pharma companies across 4,500+ research centers.

BenchSci Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BenchSci Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BenchSci's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range242
Year Founded2015
Last FundingMay 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.